Evidence map›Paper›PMID 31728673›Full record

Trial reportEuropean journal of pediatrics2020

Lower prednisone dosing for steroid-sensitive nephrotic syndrome relapse: a prospective randomized pilot study.

Yael Borovitz, Hadas Alfandary, Orly Haskin, Shely Levi, Shulamit Kaz, Miriam Davidovits, Amit Dagan

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in European journal of pediatrics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 3 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 3 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Corticosteroid therapy for nephrotic syndrome in children.The Cochrane database of systematic reviews · 2024
    Pooled it
  2. Pooled it
  3. Corticosteroid therapy for nephrotic syndrome in children.The Cochrane database of systematic reviews · 2020
    Pooled it
  4. Trial
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yael BorovitzInstitute of Nephrology, Schneider Children's Medical Center of Israel, 4920235, Petach Tikva, Israel.
Hadas AlfandaryInstitute of Nephrology, Schneider Children's Medical Center of Israel, 4920235, Petach Tikva, Israel.
Orly HaskinInstitute of Nephrology, Schneider Children's Medical Center of Israel, 4920235, Petach Tikva, Israel.
Shely LeviInstitute of Nephrology, Schneider Children's Medical Center of Israel, 4920235, Petach Tikva, Israel.
Shulamit KazInstitute of Nephrology, Schneider Children's Medical Center of Israel, 4920235, Petach Tikva, Israel.
Miriam DavidovitsInstitute of Nephrology, Schneider Children's Medical Center of Israel, 4920235, Petach Tikva, Israel.
Amit DaganInstitute of Nephrology, Schneider Children's Medical Center of Israel, 4920235, Petach Tikva, Israel. dagana@clalit.org.il.
Schneider Children's Medical Center · ILTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Relapses of steroid-sensitive nephrotic syndrome are traditionally treated with prednisone 2 mg/kg/day or 60 mg/m

Indexed as

AdolescentAnti-Inflammatory AgentsChildChild, PreschoolChronic DiseaseDose-Response Relationship, DrugDrug Administration ScheduleFemaleFollow-Up StudiesHumansIsraelMaleNephrotic SyndromePilot ProjectsPrednisoneProspective StudiesAnti-Inflammatory AgentsPrednisoneLow dosePrednisoneSteroid-sensitive nephrotic syndromeSteroid treatment

Identifiers

PMID31728673
OpenAlexW2987015318

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.